Article

Alcon launches Web site for patients with nasal allergies

Alcon Laboratories Inc. announced in a prepared statement the launch of a new online resource for patients with nasal allergies: its new Web site for olopatadine (Patanase) nasal spray, www.patanese.com.

Fort Worth, TX

―Alcon Laboratories Inc. announced in a prepared statement the launch of a new online resource for patients with nasal allergies: its new Web site for olopatadine (Patanase) nasal spray,

www.patanase.com

.

The site features facts about the causes of seasonal allergies, an interactive symptoms poll, complete product prescribing information and instructions, and a mail-in rebate for patients.

“This Web site is a great resource since more patients are doing online research to learn about their allergies,” said Bobby Lanier, MD, clinical professor at the University of North Texas Health Science Center, Fort Worth. “It addresses the important need for patients to understand their symptoms and how to get quick, safe relief.”

Olopatadine is a steroid-free nasal spray indicated for the relief of the symptoms of seasonal allergic rhinitis in patients aged 12 or more years.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
© 2025 MJH Life Sciences

All rights reserved.